Test Code Epic LAB4148 Coenzyme Q10, Total, Plasma
Additional Codes
SQ code TQ10M
Mayo TQ10
Reporting Name
Coenzyme Q10, Total, PSpecimen Type
Plasma HeparinPerforming Laboratory
Mayo Clinic Laboratories in Rochester
Useful For
Diagnosis of primary coenzyme Q10 (CoQ10) deficiencies in some patients who are not supplemented with CoQ10
Monitoring patients receiving statin therapy
Monitoring CoQ10 status during treatment of various degenerative conditions, including Parkinson and Alzheimer diseases
Providing accurate quantitation of total CoQ10 when specimens are hemolyzed
This test is not useful for distinguishing primary CoQ10 deficiencies from acquired CoQ10 deficiencies.
Ordering Guidance
This test does not quantitate reduced coenzyme Q10 (CoQ10). For reduced CoQ10, order Q10 / Coenzyme Q10, Reduced and Total, Plasma.
The most reliable test for the diagnosis of primary defects in ubiquinone (ie, CoQ10) biosynthesis is direct measurement of CoQ10 in muscle.
Necessary Information
Patient's age is required.
Specimen Required
Patient Preparation:
Fasting: 8 hours, required
Supplies: Sarstedt Aliquot Tube, 5 mL (T914)
Collection Container/Tube: Green top (lithium or sodium heparin)
Submission Container/Tube: Plastic vial
Specimen Volume: 0.5 mL plasma
Collection Instructions:
1. Immediately after collection, place specimen on wet ice. Maintain on wet ice until processing.
2. Within 3 hours of collection, centrifuge, aliquot plasma into a plastic vial, and freeze immediately.
Specimen Minimum Volume
Plasma: 0.3 mL
Specimen Stability Information
| Specimen Type | Temperature | Time |
|---|---|---|
| Plasma Heparin | Frozen (preferred) | 60 days |
| Refrigerated | 7 days | |
| Ambient | 4 days |
Reference Values
<18 years: 320-1558 mcg/L
≥18 years: 433-1532 mcg/L
Miles MV, Horn PS, Tang PH, et al. Age-related changes in plasma coenzyme Q10 concentrations and redox state in apparently healthy children and adults. Clin Chim Acta. 2004;347(1-2):139-144
Day(s) Performed
Monday through Friday
Test Classification
This test was developed and its performance characteristics determined by Mayo Clinic in a manner consistent with CLIA requirements. It has not been cleared or approved by the US Food and Drug Administration.CPT Code Information
82542
LOINC Code Information
| Test ID | Test Order Name | Order LOINC Value |
|---|---|---|
| TQ10 | Coenzyme Q10, Total, P | 27923-2 |
| Result ID | Test Result Name | Result LOINC Value |
|---|---|---|
| 36764 | CoQ10 Total | 27923-2 |
| 36765 | Interpretation (TQ10) | 59462-2 |
| 36777 | Reviewed By | 18771-6 |
Reject Due To
| Gross hemolysis | OK |
| Gross lipemia | Reject |
| Gross icterus | OK |
Method Name
Liquid Chromatography Tandem Mass Spectrometry (LC-MS/MS)
Genetics Test Information
This test is used for the diagnosis of coenzyme Q10 (CoQ10) deficiency in mitochondrial disorders. It is also used to monitor CoQ10 status in patients with mitochondrial cytopathies, patients receiving statin therapy, or during treatment of various degenerative conditions including Parkinson and Alzheimer diseases.
Method Description
Coenzyme Q10, together with other lipid soluble substances, is extracted from plasma with cold n-propanol containing coenzyme Q10-d9 as an internal standard. An aliquot of the lipid extract is analyzed by liquid chromatography tandem mass spectrometry. The isolated coenzymeQ10 peaks corresponding to the reduced form (CoQ10H2) and the oxidized form CoQ10 are quantified by measurement off extracted and analyzed calibration curves for the respective form of Q10. Chromatography is performed using a C18 (30x2.1mm) column and total analysis time is 3.5 minutes.(Unpublished Mayo method)
Report Available
2 to 4 daysSecondary ID
63148Forms
If not ordering electronically, complete, print, and send a Biochemical Genetics Test Request (T798) with the specimen.